8-KOther EventsExhibits & Filings

CVS HEALTH Corp 8-K Report, Corporate Update (Aug 23, 2021)

Filed August 23, 2021For Securities:CVS

Summary

CVS Health Corporation (CVS) announced the early results and pricing of its previously announced cash tender offer on August 23, 2021. The company has decided to upsize the tender offer, increasing the maximum amount to approximately $2.05 billion from the initially planned $2.00 billion. This increase reflects the company's intention to acquire a larger principal amount of its outstanding notes. As a result of this upsize and the early settlement date of August 24, 2021, CVS Health expects to accept for purchase the full upsized Maximum Amount. This means that no further purchases are anticipated under the tender offer after this early settlement date. Investors should note this significant debt management activity and the company's commitment to completing the offer at the revised, larger principal amount.

Key Highlights

  • 1CVS Health upsized its cash tender offer to approximately $2.05 billion.
  • 2The original tender offer amount was $2.00 billion.
  • 3The company expects to purchase the full upsized Maximum Amount of notes.
  • 4Early settlement for accepted notes is scheduled for August 24, 2021.
  • 5No additional notes are expected to be purchased after the early settlement date.
  • 6This action indicates proactive debt management by CVS Health.

Frequently Asked Questions

This filing announces the early results and pricing of CVS Health's cash tender offer for its notes, including an upsize to the maximum purchase amount and confirmation of early settlement.

CVS Health increased the maximum amount of the tender offer by approximately $49.92 million, from $2.00 billion to $2.049919 billion.

The company expects to accept for purchase the maximum amount of notes, with early settlement for validly tendered and accepted notes occurring on August 24, 2021. No further purchases are expected after this date.

This tender offer indicates that CVS Health is actively managing its debt obligations. The upsize and commitment to purchase suggest the company may be refinancing or deleveraging at favorable terms, or opportunistically repurchasing its debt.